Bio-Rad Labs (BIO) Tops Q3 EPS by 5c
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $378.61 +0.34%
Revenue Growth %: -0.4%
Financial Fact:
Research and development expense: 52.17M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: -0.4%
Financial Fact:
Research and development expense: 52.17M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q3 EPS of $0.59, $0.05 better than the analyst estimate of $0.54. Revenue for the quarter came in at $470 million versus the consensus estimate of $495.55 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Exelon (EXC) PT Lowered to $49 at Argus
- Cal-Maine Foods (CALM) PT Lowered to $80 at Stephens
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
